Skip to main content
. Author manuscript; available in PMC: 2024 May 15.
Published in final edited form as: Circulation. 2023 Nov 30;149(1):e1–e156. doi: 10.1161/CIR.0000000000001193

Recommendations for Surgical Ablation

Referenced studies that support the recommendations are summarized in the Online Data Supplement.

COR LOE Recommendations
2a B-R 1. For patients with AF who are undergoing cardiac surgery, concomitant surgical ablation can be beneficial to reduce the risk of recurrent AF.13
2a B-NR 2. In patients undergoing surgical ablation, anticoagulation therapy is reasonable for at least 3 months after the procedure to reduce the risk of stroke or systemic embolism.24
2b B-R 3. For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy a hybrid epicardial and endocardial ablation might be reasonable to reduce the risk of recurrent atrial arrhythmia.57